3 documents found, page 1 of 1
Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis:...
Nery, F; Carneiro, P; Correia, S; Macedo, C; Gandara, J; Lopes, V; Valadares, D; Ferreira, S; Oliveira, J; Teixeira Gomes, M; Miranda, HP; Rautou, PEBackground and Aims Various risk factors for portal vein thrombosis (PVT) development in patients with cirrhosis have been identified, but the role of systemic inflammatory reaction is unknown. The study aims to assess the association between markers of systemic inflammation and PVT in cirrhosis. Methods Between January 2014 and October 2015, 107 outpatients with cirrhosis and no PVT were recruited, and followe...
Porto-sinusoidal vascular disease: proposal and description of a novel entity
De Gottardi, A; Rautou, PE; Schouten, J; Rubbia-Brandt, L; Leebeek, F; Trebicka, J; Murad, SD; Vilgrain, V; Hernandez-Gea, V; Nery, F; Plessier, APortal hypertension in the absence of portal vein thrombosis and without cirrhosis, but with mild or moderate alterations of liver histology (eg, obliterative venopathy, nodular regenerative hyperplasia, or incomplete septal cirrhosis) is being increasingly recognised. Owing to the heterogeneity of causes and histological findings, a substantial number of terms have been used to describe such idiopathic non-cir...
Nonselective beta-blockers and the risk of portal vein thrombosis in patients w...
Nery, F; Correia, S; Macedo, C; Gandara, J; Lopes, V; Valadares, D; Ferreira, S; Oliveira, J; Gomes, MT; Lucas, R; Rautou, PE; Miranda, HP; Valla, DBackground Nonmalignant portal vein thrombosis is a significant event in the course of cirrhosis that can contraindicate liver transplantation and even impact survival after the surgical procedure. Risk factors are not completely known or validated and are still debated. Aim To identify in patients with cirrhosis the risk factors for portal vein thrombosis that are assessable in clinical practice. Methods Betwe...